Vaccine Manufacturing Plant Uses Standardized Production Management Software - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Vaccine Manufacturing Plant Uses Standardized Production Management Software


The Japanese biotech company Unigen implemented Werum's PAS-X Manufacturing Execution System (MES) in only four months at the company's greenfield site in Gifu, Japan, Werum reported in a press release. Unigen is a joint venture of the Japanese pharmaceutical company UMN Pharma and the heavy equipment manufacturer IHI Corporation. The plant is one of the largest for production of recombinant influenza vaccines and contract manufacturing of biopharmaceutical products that accommodates several bioreactors, each with a capacity of 21,000 liters.

At the new plant, Unigen uses a complex biopharmaceutical manufacturing process called Baculovirus Expression Vector System. For this process, Unigen required standardized production management software that is able to meet high quality and compliance standards in accordance with the Japanese zero-error tolerance. The short implementation time was possible because the MES program is standardized and was implemented using Werum’s four-phased fast-track implementation methodology: Ready, Fit, Build, and Run. PAS-X was delivered with the entire user interface in Japanese. Werum carried out this project in close cooperation with their Japanese partner, CST Chiyoda System Technologies Corporation.

Source: Werum

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here